Lexicon's stock rose 60% after securing a potential $1 billion deal with Novo Nordisk for preclinical obesity drug LX9851.

Some blood pressure medications are not the best choice anymore, either due to their side effects or limited effectiveness.

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

Milestone Pharmaceuticals hit another bump in the road in its quest to get Cardamyst approved for paroxysmal supraventricular ...

Losing weight is a common New Year’s resolution, and many people are now turning to advanced weight-loss medications like ...

The U.S. Food and Drug Administration has declined to approve Milestone Pharmaceuticals' nasal spray to treat a type of heart ...

Scientists at Johns Hopkins Medicine have discovered that an experimental drug originally developed for other health problems ...

A new study has found that combining statins - the first-line treatment for high cholesterol - and ezetimibe, another drug ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

Some drugs are known as nephrotoxic, which means that their effects can cause damage to the kidneys. Drugs such as certain ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

It’s not often the public gets to look behind the scenes of federal operations and what happens when agents encounter ...